Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EUROGIN 2011 roadmap on prevention and treatment of HPV‐related disease
Marc Arbyn, Silvia de Sanjosé, Mona Saraiya, et al.
International Journal of Cancer (2012) Vol. 131, Iss. 9, pp. 1969-1982
Open Access | Times Cited: 242

Showing 1-25 of 242 citing articles:

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis
Marc Arbyn, Freija Verdoodt, Peter J.F. Snijders, et al.
The Lancet Oncology (2014) Vol. 15, Iss. 2, pp. 172-183
Closed Access | Times Cited: 615
Historical review of the causes of cancer
Clarke Brian Blackadar
World Journal of Clinical Oncology (2016) Vol. 7, Iss. 1, pp. 54-54
Open Access | Times Cited: 327
EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection
Anna R. Giuliano, Alan G. Nyitray, Aimée R. Kreimer, et al.
International Journal of Cancer (2014) Vol. 136, Iss. 12, pp. 2752-2760
Open Access | Times Cited: 281
Cervical Cancer Immunotherapy: Facts and Hopes
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 18, pp. 4953-4973
Open Access | Times Cited: 267
Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: A systematic review and meta-analysis of randomised trials
Freija Verdoodt, Matthias Jentschke, Peter Hillemanns, et al.
European Journal of Cancer (2015) Vol. 51, Iss. 16, pp. 2375-2385
Closed Access | Times Cited: 260
High‐risk HPV testing on self‐sampled versus clinician‐collected specimens: A review on the clinical accuracy and impact on population attendance in cervical cancer screening
Peter J.F. Snijders, Viola M.J. Verhoef, Marc Arbyn, et al.
International Journal of Cancer (2012) Vol. 132, Iss. 10, pp. 2223-2236
Open Access | Times Cited: 244
Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta‐analysis
Elena‐Sophie Prigge, Marc Arbyn, Magnus von Knebel Doeberitz, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 5, pp. 1186-1198
Open Access | Times Cited: 226
Human papillomavirus-associated cancers: A growing global problem
Bhavana Rai, Anshuma Bansal, MiniP Singh
International Journal of Applied and Basic Medical Research (2016) Vol. 6, Iss. 2, pp. 84-84
Open Access | Times Cited: 185
HPV and Male Cancer: Pathogenesis, Prevention and Impact
Soumendu Patra, Harshita Shand, Sayan Ghosal, et al.
Journal of the Oman Medical Association (2025) Vol. 2, Iss. 1, pp. 4-4
Open Access | Times Cited: 2
Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
Maura L. Gillison, Xavier Castellsagué, Anil K. Chaturvedi, et al.
International Journal of Cancer (2013) Vol. 134, Iss. 3, pp. 497-507
Closed Access | Times Cited: 202
Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory
Jo Waller, Remo Ostini, Laura A.V. Marlow, et al.
Preventive Medicine (2012) Vol. 56, Iss. 1, pp. 35-40
Open Access | Times Cited: 198
Eurogin roadmap 2017: Triage strategies for the management of HPV‐positive women in cervical screening programs
Kate Cuschieri, Guglielmo Ronco, Attila T. Lörincz, et al.
International Journal of Cancer (2018) Vol. 143, Iss. 4, pp. 735-745
Open Access | Times Cited: 145
Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer
Gordana Halec, Laia Alemany, Belén Lloveras, et al.
The Journal of Pathology (2014) Vol. 234, Iss. 4, pp. 441-451
Open Access | Times Cited: 135
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
Nicolas Wentzensen, Marc Arbyn, Johannes Berkhof, et al.
International Journal of Cancer (2016) Vol. 140, Iss. 10, pp. 2192-2200
Open Access | Times Cited: 93
Changes of the vaginal microbiota in HPV infection and cervical intraepithelial neoplasia: a cross-sectional analysis
Wenyu Lin, Qiaoyu Zhang, Yaojia Chen, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 57
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
Sheela Rao, Gayathri Anandappa, Jaume Capdevila, et al.
ESMO Open (2022) Vol. 7, Iss. 4, pp. 100529-100529
Open Access | Times Cited: 53
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 40
Viruses in glioblastoma: an update on evidence and clinical trials
Bavani Gunasegaran, Caroline L. Ashley, Felix Marsh‐Wakefield, et al.
BJC Reports (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 9
Reasons for non-attendance to cervical screening and preferences for HPV self-sampling in Dutch women
Remko P. Bosgraaf, Pleun J. W. Ketelaars, Viola M.J. Verhoef, et al.
Preventive Medicine (2014) Vol. 64, pp. 108-113
Closed Access | Times Cited: 85
Cervical cancer screening: on the way to a shift from cytology to full molecular screening
Maaike G. Dijkstra, Peter J.F. Snijders, Marc Arbyn, et al.
Annals of Oncology (2014) Vol. 25, Iss. 5, pp. 927-935
Open Access | Times Cited: 85
Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer
Michele Mondini, Mevyn Nizard, Thi Tran, et al.
Molecular Cancer Therapeutics (2015) Vol. 14, Iss. 6, pp. 1336-1345
Open Access | Times Cited: 84
Implementation of Human Papillomavirus Immunization in the Developing World
Mark Kane, Beatriz Serrano, Silvia de Sanjosé, et al.
Vaccine (2012) Vol. 30, pp. F192-F200
Closed Access | Times Cited: 83
Maturation of the Human Papillomavirus 16 Capsid
Giovanni Cardone, Adam L. Moyer, Naiqian Cheng, et al.
mBio (2014) Vol. 5, Iss. 4
Open Access | Times Cited: 83
Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer
Chia-Ching J Wang, Joseph A. Sparano, Joel M. Palefsky
Surgical Oncology Clinics of North America (2016) Vol. 26, Iss. 1, pp. 17-31
Open Access | Times Cited: 80
Cervical Cancer in Ethiopia: Survival of 1,059 Patients Who Received Oncologic Therapy
Eva Johanna Kantelhardt, Ulrike Moelle, Matthias Begoihn, et al.
The Oncologist (2014) Vol. 19, Iss. 7, pp. 727-734
Open Access | Times Cited: 79
Page 1 - Next Page

Scroll to top